Aeternum Health (AETN) Shares Outstanding (Weighted Average) (2010 - 2026)

Aeternum Health (AETN) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $50.3 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $50.3 million, up 3.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $50.3 million (up 3.51% YoY), and the FY2025 annual result was $49.0 million, up 1.17% from the prior year.
• Shares Outstanding (Weighted Average) advanced to $50.3 million in Q1 2026 per AETN's latest filing, from $49.0 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $50.3 million in Q1 2026 and troughed at $5.8 million in Q1 2022.
• A 5-year average of $39.1 million and a median of $48.5 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) soared 719.31% in 2023, then advanced 1.17% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $9.4 million in 2022, then surged by 415.41% to $48.5 million in 2023, then changed by 0.0% to $48.5 million in 2024, then increased by 1.17% to $49.0 million in 2025, then climbed by 2.59% to $50.3 million in 2026.
• Business Quant data shows AETN's Shares Outstanding (Weighted Average) at $50.3 million in Q1 2026, $49.0 million in Q4 2025, and $49.2 million in Q3 2025.